10.1371/journal.pone.0141137.g006 Harry A. Quigley Harry A. Quigley Ian F. Pitha Ian F. Pitha Derek S. Welsbie Derek S. Welsbie Cathy Nguyen Cathy Nguyen Matthew R. Steinhart Matthew R. Steinhart Thao D. Nguyen Thao D. Nguyen Mary Ellen Pease Mary Ellen Pease Ericka N. Oglesby Ericka N. Oglesby Cynthia A. Berlinicke Cynthia A. Berlinicke Katherine L. Mitchell Katherine L. Mitchell Jessica Kim Jessica Kim Joan J. Jefferys Joan J. Jefferys Elizabeth C. Kimball Elizabeth C. Kimball RTPCR of angiotensin receptor expression. Public Library of Science 2015 IOP.ConclusionsThe neuroprotective effect tail cuff device transcription polymerase chain reaction RGC loss angiotensin receptors 3 day IOP elevations control glaucoma eyes scleral thickness regression model p enalapril blood pressure Experimental Glaucoma PurposeTo Alters Scleral Remodeling CD 1 mice Losartan Treatment Protects Retinal Ganglion Cells losartan treatment decreases Axonal transport blockade 2015-10-27 03:50:48 Figure https://plos.figshare.com/articles/figure/_RTPCR_of_angiotensin_receptor_expression_/1586590 <p>Graph plots the relative expression of five tissues tested for the presence of AT1a, AT1b, and AT2 receptors- kidney, adrenal gland, retina, sclera and optic nerve from a CD1 mouse. To help normalize the results, a value was calculated by dividing the GAPDH primer treated tissue value by the mean quantification cycle (Cq) value for AT1A, AT1B, or AT2 primer tissue (relative expression). A lower value than 1 indicates a lower value for that receptor in tissue compared to GAPDH.</p>